Baseline Quantitative Hepatitis B Core Antibody Level strongly Predicts 240-week Treatment Response in HBeAg-positive Chronic Hepatitis B Patients Receiving Entecavir

HEPATOLOGY(2016)

引用 0|浏览18
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要